SMStephanie D. Mes

Stephanie D. Mes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stephanie D. Mes has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Bas Joris Heijnen

    Department of Otorhinolaryngology and Head and Neck Surgery, Leiden University Medical Centre, 2333 ZA Leiden, The Netherlands

    3 shared publications
  • Elisabeth V. Sjögren

    Department of Otolaryngology and Head- and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands

    3 shared publications
  • Martine Hendriksma

    Department of Otolaryngology and Head- and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands

    3 shared publications
  • Antonius P. M. Langeveld

    Department of ENT, Head and Neck Surgery H5-Q, Leiden University Medical Center, Leiden, The Netherlands

    2 shared publications
  • Jeroen C. Jansen

    Department of Otolaryngology and Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands

    2 shared publications
  • A. P. M. Langeveld

    Department of Otolaryngology and Head- and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands

    1 shared publication

Latest Publications

  • Open Access

    Laryngeal reinnervation for unilateral vocal fold paralysis in adults; a systematic review of the literature for the clinician

    by Stephanie D. Mes, Bas J. Heijnen, Martine H. Hendriksma, Antonius P.M Langeveld, Emilie A.C. Dronkers, Elisabeth V. Sjögren

    Purpose: Unilateral vocal fold paralysis (UVFP), resulting from recurrent laryngeal nerve injury, significantly impairs phonation and reduces quality of life. Laryngeal reinnervation, including ansa-to-recurrent (ansaNSR) and nerve-muscle pedicle reinnervation combined with arytenoid adduction (NMPR + AA), has gained attention as a durable treatment option. This systematic review aims to evaluate the outcomes of laryngeal reinnervation, identify predictive factors and highlight knowledge gaps relevant to clinical practice. Methods: A systematic search of PubMed, Embase, Web of Science, the Cochrane Library and Emcare identified 42 studies. Outcome measures included perceptual, acoustic, aerodynamic, videostroboscopic and patient-reported outcomes. The risk of bias was assessed using the Methodological Index for Non-Randomized Studies (MINORS) tool. Weighted mean improvements were calculated for clinically relevant parameters. Results: We included forty-two studies ( N = 1 859 patients) in our review. These studies demonstrated high rates of voice improvement, primarily based on data from the ansaNSR ( N = 1 369) and NMPR + AA ( N = 278) techniques. Age and duration of denervation emerged as the most influential predictive factor. Younger patients (< 60 years) and those with shorter denervation periods (< 2 years) had better outcomes, although successful results were also observed beyond these thresholds. The predictive value of preoperative laryngeal electromyography (LEMG), etiology of UVFP and clinical presentation remains inconclusive. Conclusion: Laryngeal reinnervation (ansaNSR and NMPR + AA) is effective for UVFP, offering durable voice improvements with minimal complication rates. Future research should focus on standardizing outcome measurements, clarifying predictive factors and refining patient selection to enhance clinical decision-making.


  • Open Access

    Voice outcome in medialisation thyroplasty with and without arytenoid adduction: a prospective comparison using intraoperative voice measurements

    by S. D. Mes, M. A. van der Jagt, J. C. Jansen, A. P. M. Langeveld, E. V. Sjögren, B. J. Heijnen

    Purpose: Arytenoid adduction as an addition to medialisation thyroplasty is highly advocated by some surgeons in selected cases but deemed less necessary by others in patients with unilateral vocal fold paralysis. This study aims to evaluate the additional benefits on voice outcome of arytenoid adduction in patients with unilateral vocal fold paralysis undergoing medialisation thyroplasty using intra-operative voice measurements. Design/methods: A prospective study was conducted. Voice audio recordings were obtained at 4 moments; 1. direct prior to the start of surgery, 2. during surgery after medialisation thyroplasty, 3. during surgery after medialisation and arytenoid adduction, 3 months postoperative. At these same timepoints patients rated their own voice on a numeric rating scale between 0 and 10. The blinded recordings were rated by consensus in a team of experienced listeners, using the Grade of the GRBAS scale. Furthermore, the Voice Handicap Index was administered before and at 3 months after surgery. Results: Ten patients who underwent medialisation and arytenoid adduction at our tertiary referral hospital between 2021 and 2022, were included. One patient was excluded after surgery. The intraoperative measurements showed a Grade score of 1.4 preoperatively, improving to 1.2 after medialisation, 1.2 after medialisation and arytenoid adduction, and further improving to 0.4 at 3 months postoperative, which was a not statistically significant improvement (p = 0.2). The intraoperative subjective numeric rating scale showed a statistically significant improvement from 3.9 preoperatively, to 6.1 after medialisation, 7.1 after medialisation and arytenoid adduction and a 7.6 at 3 months postoperative (p = 0.001). The Voice Handicap Index total score showed a statistically significant improvement from 71 points before surgery to 13 at 3 months after surgery (p = 0.008). Conclusions: Our study using intraoperative voice measurements indicate that the addition of arytenoid adduction to medialisation thyroplasty is a benefit in selected patients although more studies are needed due to the many limitations inherent to this field of investigation.


  • Multidimensional assessment of voice quality after injection augmentation of the vocal fold with autologous adipose tissue or calcium hydroxylapatite

    by Stephanie D. Mes, Edela Smajlović, Bas J. Heijnen, Martine Hendriksma, Jeroen C. Jansen, Antonius P. M. Langeveld, Elisabeth V. Sjögren

    Purpose The purpose of this study was to evaluate short- and long-term outcome of injection augmentation with autologous adipose tissue (AAT) and calcium hydroxylapatite injection (CAHA) in patients with a unilateral vocal fold paralysis (UVFP). Design/methods A retrospective cohort study was performed in patients diagnosed with UVFP, who had received injection augmentation with AAT or CAHA. Multidimensional voice analysis was performed before, 3 and 12 months after injection. This analysis included patient self-assessment (Voice Handicap Index-30), perceptual (overall dysphonia grade according to the GRBAS scale), aerodynamic (MPT, s/z ratio) and acoustic (fundamental frequency, dynamic range) parameters. Effects were assessed using a linear mixed model analysis. Results Forty-six patients were available for evaluation, with a total of 53 injection augmentations (AAT n = 39; CAHA n = 14). We found significant improvement of patient self-assessment and perceptive voice outcome at 3 months, which were maintained at 12 months. In the CAHA group, s/z ratio and dynamic range of extreme frequencies also improved significantly over time. No statistically significant differences were found between the two treatments (AAT vs. CAHA). No major complications were reported. Conclusion This study, using a guide-line recommended panel of outcome parameters, shows a high success rate of injection augmentation with AAT or CAHA for patients with UVFP at 12 months with significant improvement in most voice outcome parameters, although voices do not completely normalize. There is no significant difference in outcome between the two materials.


  • Long-term voice outcomes of laryngeal framework surgery for unilateral vocal fold paralysis

    by Stephanie D. Mes, Martine Hendriksma, Bas J. Heijnen, Ben F. J. Goudsmit, Jeroen C. Jansen, Antonius P. M. Langeveld, Elisabeth V. Sjögren

    Objective To evaluate the short- and long-term voice outcomes after unilateral medialization thyroplasty (MT) and unilateral medialization thyroplasty with arytenoid adduction (MT + AA) in patients with unilateral vocal fold paralysis. Methods Voice outcomes were assessed preoperatively, and postoperatively at 3 and 12 months according to a standardized protocol. Voice assessment was performed using Voice Handicap Index (VHI), GRBAS Grade, Maximum Phonation Time (MPT), s/z-ratio and subjective numeric rating scales on voice quality, effort, performance and influence on life. Results Sixty-one patients were included (34 MT and 27 MT + AA). Significant pre- to postoperative improvements were seen in all voice outcome parameters. No significant differences in post-operative values were identified between the groups. Conclusion Based on our findings, we conclude that patients with unilateral vocal fold paralysis who undergo MT and MT + AA achieve comparable and significant long time voice improvement, although voices do not completely normalize. We also conclude that this does not mean that AA is a superfluous procedure, but can indicate the accurate identification of patients in need of the additional AA procedure based on clinical parameters.